Concepedia

Rebecca J. Boohaker

RJ

Statistics

Publications

19

Citations

708

H-Index

15

Active since

2007

Affiliations

Southern Research Institute(Current)

University of Alabama at Birmingham

Tianjin Medical University Cancer Institute and Hospital

University of Central Florida

First Affiliated Hospital of Xi'an Jiaotong University

Rebecca J. Boohaker is an author at Southern Research Institute specializing in oncology, molecular oncology, and life sciences.

ORCID

Publications per year

2007–2023

19

Publications

19

Fc receptor-like 5 inhibits B cell activation via SHP-1 tyrosine phosphatase recruitment

Christopher L. Haga, Götz R. A. Ehrhardt, Rebecca J. Boohaker et al. · Proceedings of the National Academy of Sciences · 2007 · 106 citations · Full text

, , +17

KIFC1 is a novel potential therapeutic target for breast cancer

Yonghe Li, Wenyan Lü, Dongquan Chen et al. · Cancer Biology & Therapy · 2015 · 100 citations · Full text

, , +13

Discovery of a novel inhibitor of kinesin-like protein KIFC1

Wei Zhang, Ling Zhai, Yimin Wang et al. · Biochemical Journal · 2016 · 65 citations · Full text

, , +15

The CT20 peptide causes detachment and death of metastatic breast cancer cells by promoting mitochondrial aggregation and cytoskeletal disruption

M W Lee, Rania Bassiouni, Nicklaus A. Sparrow et al. · Cell Death and Disease · 2014 · 48 citations · Full text

, , +14

Rational design and development of a peptide inhibitor for the PD-1/PD-L1 interaction

Rebecca J. Boohaker, Vijaya Sambandam, Isaac Segura et al. · Cancer Letters · 2018 · 43 citations

, , +16

1–5 of 19